Category: Pulmonology
Study Shows Omega-3 Fatty Acids May Offer New Hope in Treating Pulmonary Fibrosis and COPD
Overview of the Study In a new study, a new benefit of omega-3 has just been documented by a team of University of Virginia intensive care physicians, who revealed …Managing the Flu in a COVID World: Prevention, Treatment, Warning Signs, and What Still Works
Key Takeaways Most flu cases resolve in 7–10 days, but high-risk groups should watch for signs of complications. Antivirals like Tamiflu may help if taken within 48 hours, but …The Role of Type I Interferon Autoantibodies in Exacerbating Influenza and COVID-19 Cases
Why do some people get “severe flu” or “severe COVID”? French researchers have found the answer. More precisely, they have understood the biological mechanism underlying the predisposition to severe …Comprehensive Guide to Pulmonary Embolism: Insights into Causes, Symptoms, Diagnosis, and Advanced Treatment Options
Pulmonary embolism is a health condition where the tiny arteries of the lungs are obstructed by an embolus. An embolus is a particle that has traveled through the bloodstream …Optimizing Quality of Life in COPD Sufferers: A Resource Guide for Patients and Caregivers
Chronic obstructive pulmonary disease (COPD) is a disease that could destabilize patients and even their caregivers if not handled promptly and adequately. Instituting a multidisciplinary approach including self-management tactics …Novel Treatment For Progressive Pulmonary Fibrosis Gets Breakthrough Therapy Designation From the FDA
The U.S. Food and Drug Administration (FDA) has granted a novel antifibrotic Breakthrough Therapy designation. This move could speed up the therapy’s development for the treatment of people with …Study Reveals that Even 13 Days Post-Cold Exposure, You’re Still at Risk for Deadly Pneumonia!
Pneumonia, a prevalent respiratory ailment predominantly instigated by infectious agents, continually proves to be a pressing health concern across the globe. While numerous factors play a role in the …Preventing Ventilator-Associated Pneumonia: A Case for Inhaled Amikacin
Ventilator-associated pneumonia (VAP) remains a significant clinical concern in intensive care units worldwide. This nosocomial infection complicates the treatment trajectory of critically ill patients, prolonging hospital stays, increasing costs, …